C4 Therapeutics (CCCC) IPO Opens 40% Higher

Today's IPO for C4 Therapeutics, Inc. (C4T) (NASDAQ: CCCC) opened for trading at $26.60 after pricing of its upsized initial public offering of 9.6 million shares of common stock at a public offering price of $19 per share.

Additionally, C4T has granted the underwriters a 30-day option to purchase up to an additional 1.44 million shares of common stock at the initial public offering price, less underwriting discounts and commissions.

Jefferies, Evercore ISI, BMO Capital Markets and UBS Investment Bank are acting as joint book-running managers for the offering.

You May Also Be Interested In

• Attovia Therapeutics files for IPO on Nasdaq
• Agility Robotics files to go public via SPAC merger with Churchill XI
• Deepseek Is Said To Prepare For Ipo Filing As Soon As This Year - Bloomberg